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S3. Long-term high-dose 17-DMAG treatment started after transfection does not induce specific inhibition of virus replication. LMH cells were transfected with a DHBV expression vector. Therafter, cells were cultured in the presence of the indicated concentrations of 17-DMAG and harvested 48 h (left panels) or 72 h later (rigth panels). Viral DNA was isolated from cytoplasmic lysates as outlined in Materials and Methods and detected by Southern blotting and autoradiography (top). In all samples, the typical relaxed circular (RC), double-stranded linear (dsL) and some single-stranded (ss) DNA forms of the 3 kb DHBV genome were present; M denotes a 3 kb linear DNA marker fragment. RC-DNA signals were quantified by phosphorimaging and are given relative to the untreated sample set at 100% ("absolute DNA signal"). These values suggested a modest (48 h) to strong (72 h) decrease in viral replication at the highest drug concentrations. However, the source lysates for the DNA samples contained fewer viable cells. To account for this loss equal aliquots from all lysates were analyzed by Western blotting for tubulin using a chemiluminescent substrate. Band intensities were quantified using a Fuji LAS3000 imaging instrument, and normalized to the untreated sample set at 100%. DNA signal intensities normalized for tubulin content did not show any decrease. The nominal increase at the highest inhibitor concentrations is likely to reflect the difficulty in accurately quantifying the weak tubulin Western blot signals. However, SDS-PAGE analysis of the lysates, plus of an additional untransfected control lysate (Ø), and subsequent Coomassie-Blue staining confirmed a strong loss of total protein in these samples (lower panels), particularly after 72 h of treatment. Thus no specific inhibition of viral replication by 17-DMAG occurred under these conditions. Figure S4 S4. High-dose 17-DMAG treatment started 1 h prior to transfection does not induce specific inhibition of virus replication. LMH cells were transfected with a DHBV expression vector as describted in figure S3 , except 17-DMAG was added 1 h prior to transfection and maintained at the indicated concentrations troughout. Cells were harvested 24 h (left panels) or 48 h later (right panels). Viral DNA was analyzed by Southern blotting (top). Total protein was analyzed by SDS-PAGE and Coomassie-Blue staining; in addition, total protein concentration was determined using the BCA assay as recommended by the manufacturer (Pierce); values were normalized to that of the untreated sample set as 100%.
DNA signals normalized to total protein content of the source lysates showed no inhibition by the drug. Lysates were also tested for Hsp90 and Hsc/Hsp70 by Western blotting; tubulin served as a loading control approximately reflecting total protein content. Hsp90 and Hsp70 signal intensities were monitored using an LAS3000 instrument, then normalized for the total protein content in the corresponding lysate. Hsp90 concentration was increased in all treated samples by 1.4-to 3.1-fold, Hsc70/Hsp70 by 1.9-to 4.6-fold. 
